Company Profiles

driven by the PitchBook Platform

Nuclea Biotechnologies

Description

Developer of clinical diagnostic tests for colon, breast, leukemia and other cancers. The company helps in development and commercialization of clinical diagnostic assays identifying gene and protein expression profiles characteristic of an individual's tumor or disease.

2005

Founded

PRIVATE

Status

51-200

Employees

Series D

Latest Deal Type

$1.01M

Latest Deal Amount

$45.4M

Total Amount Raised

Description

Developer of clinical diagnostic tests for colon, breast, leukemia and other cancers. The company helps in development and commercialization of clinical diagnostic assays identifying gene and protein expression profiles characteristic of an individual's tumor or disease.

Website:

www.nucleabio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Therapeutic Devices

Other Industries

Diagnostic Equipment

Primary Office

46-48 Elm Street Pittsfield, MA 01201United States +1 (617) 492-3900
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Nuclea Biotechnologies's full profile, request a free trial.

Nuclea Biotechnologies Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Nuclea Biotechnologies Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Nuclea Biotechnologies Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Massachusetts Life Sciences CenterGovernmentMinority000 0000000 0000
Morgan Stanley Expansion CapitalPE/BuyoutMinority000 0000000 0000
PEI FundsSecondary BuyerMinority000 0000000 0000
Vietnam PartnersVenture CapitalMinority000 0000000 0000
Massachusetts Life Sciences Center Government
Morgan Stanley Expansion Capital PE/Buyout
PEI Funds Secondary Buyer
Vietnam Partners Venture Capital

Nuclea Biotechnologies Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Donald PogorzelskiPresident & Chief Executive Officer
Bernard WhitneyChief Financial Officer
Robert PierceChief Financial Officer
Mary LopezChief Operating Officer & Vice President of Proteomics Discovery
Paula Evans JDExecutive Vice President & Chief Legal Officer
Donald Pogorzelski President & Chief Executive Officer
Bernard Whitney Chief Financial Officer
Robert Pierce Chief Financial Officer
Mary Lopez Chief Operating Officer & Vice President of Proteomics Discovery
Paula Evans JD Executive Vice President & Chief Legal Officer

Nuclea Biotechnologies Board Members (4)

NameRepresentingRoleSinceContact
Info
Charles Stetson Jr.PEI FundsCo Founder & Managing Director000 0000
Gunnar FremuthPEI FundsManaging Director000 0000
Richard VietorPEI FundsVenture Partner000 0000
William HarmanSelfBoard Member000 0000
Charles Stetson Jr. Co Founder & Managing Director PEI Funds
Gunnar Fremuth Managing Director PEI Funds
Richard Vietor Venture Partner PEI Funds
William Harman Board Member Self
Request full access to PitchBook